Abbott Laboratories releases software fixes for pacemakers that could allow an attacker to wirelessly access the devices and steal personal data, drain the battery and disrupt normal life-sustaining operations.

The FDA sent Abbott Laboratories a warning letter citing that it had inadequately addressed the security of the maligned Merlin@home Transmitter.